Acasti Pharma reported $-2.53M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Acasti Pharma USD -2.53M 560K Sep/2025
Addus HomeCare USD 32.94M 50K Sep/2025
Amarin USD -1.7M 8.47M Sep/2025
Cassava Sciences USD -11.86M 2.23M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Option Care Health USD 84.51M 1.8M Sep/2025
Organigram Holdings CAD -28.05M 7.76M Sep/2025
Tilray USD -20.01M 9.34M Sep/2025